Supernus Pharmaceuticals, Inc.

SUPN · NASDAQ
Analyze with AI
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Assets
Cash & Equivalents$69,331$75,054$93,120$203,434
Short-Term Investments$384,281$179,820$368,214$136,246
Receivables$142,077$144,155$165,497$148,932
Inventory$54,293$77,408$91,541$85,959
Other Curr. Assets$36,088$16,676$15,779$27,019
Total Curr. Assets$686,070$493,113$734,151$601,590
Property Plant & Equip (Net)$11,545$13,530$15,173$16,955
Goodwill$117,019$117,019$117,019$117,516
Intangibles$521,912$599,889$702,463$784,693
Long-Term Investments$0$16,617$93,896$119,166
Tax Assets$0$0$0$0
Other NC Assets$31,527$37,505$39,806$49,232
Total NC Assets$682,003$784,560$968,357$1,087,562
Other Assets$0$0$0$0
Total Assets$1,368,073$1,277,673$1,702,508$1,689,152
Liabilities
Payables$4,587$1,964$10,543$9,331
Short-Term Debt$6,889$8,331$408,759$6,477
Tax Payable$0$0$0$0
Deferred Revenue$0$0$0$0
Other Curr. Liab.$280,921$279,901$268,656$299,571
Total Curr. Liab.$292,397$290,196$687,958$315,379
LT Debt$27,382$33,196$35,998$420,550
Deferred Rev, NC$0$0$0$0
Deferred Tax Liab, NC$4,961$24,963$49,809$85,355
Other NC Liab.$7,600$7,802$42,539$52,017
Total NC Liab.$39,943$65,961$128,346$557,922
Other Liabilities$0$0$0$0
Cap. Leases$34,271$41,527$42,789$47,775
Total Liabilities$332,340$356,157$816,304$873,301
Equity
Pref Stock$0$0$0$0
Common Stock$56$55$54$53
Retained Earnings$556,426$482,561$481,245$379,922
AOCI-$189-$593-$3,210$1,539
Other Equity$479,440$439,493$408,115$434,337
Total Equity$1,035,733$921,516$886,204$815,851
Supplemental Information
Minority Interest$0$0$0$0
Total Liab. & Tot. Equity$1,368,073$1,277,673$1,702,508$1,689,152
Net Debt-$35,060-$33,527$351,637$223,593